Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
freeze-dried human rabies vaccine (Vero cell) (18264c)
- Development stage
- Unknown
- Lead developer
- Shandong Yidu Biotechnology
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Yidukangda is a freeze-dried human rabies vaccine (Vero cell) developed and manufactured by Shandong Yidu Biotechnology. It is an inactivated viral vaccine produced by cultivating the rabies fixed virus (CTN-1V strain) in Vero cells, followed by concentration, purification, and inactivation with beta-propiolactone. The vaccine is indicated for post-exposure prophylaxis to prevent rabies infection following animal bites or scratches, as well as for pre-exposure immunization in high-risk individuals. It functions by stimulating the host immune system to produce specific neutralizing antibodies that neutralize the rabies virus before it can enter the central nervous system. The product was approved by the China National Medical Products Administration (NMPA) and is supplied as a freeze-dried powder for intramuscular injection.
- Brand names
- Yidukangda
- Other names
- Human rabies vaccine (Vero cell)冻干人用狂犬病疫苗(Vero细胞)
Beyond the preview
Go deeper on freeze-dried human rabies vaccine (Vero cell) (18264c).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on freeze-dried human rabies vaccine (Vero cell) (18264c).